Novel Alzheimer's Drug Reduces Inflammation in the Brain

A potential new Alzheimer’s drug represses the harmful inflammatory response of the brain’s immune cells, reducing disease pathology, preserving neurons and improving cognition in preclinical tests.

Related Keywords

Manolis Kellis ,Elizabeta Gjoneska ,William Ralvenius ,Andreas Pfenning ,Li Huei Tsai ,Carnegie Mellon University ,National Institutes Of Health ,Picower Institute ,Technology Network ,Picower Institute For ,Brain Initiative ,Picower Professor ,Aging Brain ,National Institutes ,Science Professor Manolis Kellis ,Carnegie Mellon ,Water Maze ,